CA2510964A1 - Phenoxyalkylfuranes therapeutiques et intermediaires pour leur production - Google Patents

Phenoxyalkylfuranes therapeutiques et intermediaires pour leur production Download PDF

Info

Publication number
CA2510964A1
CA2510964A1 CA002510964A CA2510964A CA2510964A1 CA 2510964 A1 CA2510964 A1 CA 2510964A1 CA 002510964 A CA002510964 A CA 002510964A CA 2510964 A CA2510964 A CA 2510964A CA 2510964 A1 CA2510964 A1 CA 2510964A1
Authority
CA
Canada
Prior art keywords
phenoxyalkylfurans
therapeutic
intermediates therefor
alkyl
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002510964A
Other languages
English (en)
Other versions
CA2510964C (fr
Inventor
David J. Aldous
Thomas R. Bailey
Guy Dominic Diana
Theodore J. Nitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi-Synthelabo, Inc.
David J. Aldous
Thomas R. Bailey
Guy Dominic Diana
Theodore J. Nitz
Sanofi Winthrop, Inc.
Sanofi Pharmaceuticals, Inc.
Sanofi-Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/242,528 external-priority patent/US5514679A/en
Application filed by Sanofi-Synthelabo, Inc., David J. Aldous, Thomas R. Bailey, Guy Dominic Diana, Theodore J. Nitz, Sanofi Winthrop, Inc., Sanofi Pharmaceuticals, Inc., Sanofi-Synthelabo filed Critical Sanofi-Synthelabo, Inc.
Publication of CA2510964A1 publication Critical patent/CA2510964A1/fr
Application granted granted Critical
Publication of CA2510964C publication Critical patent/CA2510964C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002510964A 1994-05-13 1995-05-11 Phenoxyalkylfuranes therapeutiques et intermediaires pour leur production Expired - Lifetime CA2510964C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/242,528 1994-05-13
US08/242,528 US5514679A (en) 1994-05-13 1994-05-13 Therapeutic phenoxyalklpyridazines and intermediates therefor
CA002190129A CA2190129C (fr) 1994-05-13 1995-05-11 Phenoxyalkylpyridazines therapeutiques et leurs intermediaires

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002190129A Division CA2190129C (fr) 1994-05-13 1995-05-11 Phenoxyalkylpyridazines therapeutiques et leurs intermediaires

Publications (2)

Publication Number Publication Date
CA2510964A1 true CA2510964A1 (fr) 1995-11-23
CA2510964C CA2510964C (fr) 2009-06-30

Family

ID=35276910

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002510964A Expired - Lifetime CA2510964C (fr) 1994-05-13 1995-05-11 Phenoxyalkylfuranes therapeutiques et intermediaires pour leur production

Country Status (1)

Country Link
CA (1) CA2510964C (fr)

Also Published As

Publication number Publication date
CA2510964C (fr) 2009-06-30

Similar Documents

Publication Publication Date Title
KR100257619B1 (en) Azole compounds, their production and use
FI931202A (fi) Antifungala cykliska peptider och foerfarande foer framstaellning av dessa
CA2156078A1 (fr) Nouvelles imidazopyridines
HK1019878A1 (en) Total synthesis of antitumor acylfulvenes.
AU9107491A (en) 1,4-benzothiazepine derivative
ZA927606B (en) Antifungal agent.
HK1012341A1 (en) Pyrrolocarbazole
BG104569A (en) Substituted 2-benzylamino-2-phenyl-acetamide compounds
EP0774257A3 (fr) Dérivés de pipérazine et homopipérazine pour l'inhibition de l'adhésion et l'infiltration cellulaire
CA2103072A1 (fr) Devires de la pleuromutiline
TWI265161B (en) Oxime compounds, their use, and intermediates for their production
CA2510964A1 (fr) Phenoxyalkylfuranes therapeutiques et intermediaires pour leur production
AU623500B2 (en) Carboxylimino benzothiazole derivatives
EP0717039A4 (fr) Nouveau compose du type triazol, son procede de production, et agent pesticide
EP0516860A4 (en) Chromone derivative and aldose reductase inhibitor containing the same as active ingredient
CA2111096A1 (fr) Agents hypoglycemiants de type thiazolidinedione
GR3020420T3 (en) Alkyl derivatives of trazodone with cns activity.
CA2027542A1 (fr) Enaminocetones cycliques absorbant les uv
GB9015485D0 (en) Heterocyclic derivatives
CA2036643A1 (fr) Esters contenant du soufre en tant que synergiseur d'antioxydant phenolique et amine
EP0443474A3 (en) 1-phenoxycarbonyl-2-pyrrolidinone derivatives and nootropic agents
TW239123B (fr)
MY109672A (en) Azole compounds, their production and use
TW270112B (en) Novel compounds capable of lowering blood-lipid activity and its production process and its novel intermediates

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20150511